Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis

被引：29
|
作者：
Hafkin, Jeffrey [1 ]
Hittel, Norbert [2 ]
Martin, Alexandra [2 ]
Gupta, Rajesh [1 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat Inc, Rockville, MD USA
[2] Otsuka Novel Prod GmbH, Munich, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 53卷 / 01期
关键词：
D O I：
10.1183/13993003.01154-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
    Cox, V
    Brigden, G.
    Crespo, R. H.
    Lessem, E.
    Lynch, S.
    Rich, M. L.
    Waning, B.
    Furin, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (04) : 407 - +
  • [2] Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging
    Li, Yang
    Sun, Feng
    Zhang, Wenhong
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (01) : 98 - 105
  • [3] Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid
    Hwang, Hyeontaek
    Kang, Hyungseok
    Kwon, Yong-Soo
    Jeon, Doosoo
    Shim, Tae Sun
    Yim, Jae-Joon
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (08) : 1362 - 1369
  • [4] Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
    Kim, Cheon Tae
    Kim, Tae-Ok
    Shin, Hong-Joon
    Ko, Young Chun
    Choe, Yeong Hun
    Kim, Hak-Ryul
    Kwon, Yong-Soo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [5] Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis
    Alghamdi, Wael A.
    Al-Shaer, Mohammad H.
    Kipiani, Maia
    Barbakadze, Ketevan
    Mikiashvili, Lali
    Kempker, Russell R.
    Peloquin, Charles A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (04) : 1019 - 1024
  • [6] Delamanid in the treatment of multidrug-resistant tuberculosis
    Gupta, R.
    Wells, C. D.
    Hittel, N.
    Hafkin, J.
    Geiter, L. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S33 - S37
  • [7] Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
    Pecora, Francesco
    Dal Canto, Giulia
    Veronese, Piero
    Esposito, Susanna
    MICROORGANISMS, 2021, 9 (05)
  • [8] Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid
    Lee, Hoon Hee
    Jo, Kyung-Wook
    Yim, Jae-Joon
    Jeon, Doosoo
    Kang, Hyungseok
    Shim, Tae Sun
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 98 : 478 - 485
  • [9] Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea
    Kang, Hyungseok
    Jo, Kyung-Wook
    Jeon, Doosoo
    Yim, Jae-Joon
    Shim, Tae Sun
    RESPIRATORY MEDICINE, 2020, 167
  • [10] Profile of delamanid for the treatment of multidrug-resistant tuberculosis
    Szumowski, John D.
    Lynch, John B.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 677 - 682
12345